-transparent.png){kind=logo}
Peritoneovenous shunts have become an accepted mode of therapy for ascites refractory to medical treatment. However, their use is known to be associated with significant morbidity and mortality. Reported is the case of a patient with a Denver shunt who developed massive intracardiac thrombosis and subsequent shunt malfunction, despite preserved shunt patency.
Related Publications
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
August 1982,
American heart journal,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
August 1983,
Journal of the American College of Cardiology,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
December 2015,
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
August 1981,
British heart journal,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
January 2009,
Annals of pediatric cardiology,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
July 1986,
The American journal of cardiology,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
March 1984,
The American journal of cardiology,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
January 1988,
Revista espanola de cardiologia,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
March 2016,
The Journal of emergency medicine,
V Ugolini, and
J F Norcross, and
J T Schreiber, and
R E Kuntz, and
A L Taylor
December 1991,
Kokyu to junkan. Respiration & circulation,
